Взаимодействие полимерных микрочастиц геля с гладкой поверхностью и мембранным покрытием

Contributors: Пискунов, Максим Владимирович

Subject Terms: гели, гладкие поверхности, взаимодействия, биомедицинские технологии, промышленные теплотехнологии, полимерные микрочастицы, мембранные покрытия

File Description: application/pdf

Access URL: http://earchive.tpu.ru/handle/11683/76002

Взаимодействие полимерных микрочастиц геля с гладкой поверхностью и мембранным покрытием

Authors: Пискунова, Александра Евгеньевна, Хомутов, Никита Андреевич

Contributors: Пискунов, Максим Владимирович

Subject Terms: взаимодействия, полимерные микрочастицы, гели, гладкие поверхности, мембранные покрытия, биомедицинские технологии, промышленные теплотехнологии

File Description: application/pdf

Relation: info:eu-repo/grantAgreement/RSF//22-29-20109; Бутаковские чтения : материалы II Всероссийской с международным участием молодежной конференции, 13-15 декабря 2022 г., Томск; http://earchive.tpu.ru/handle/11683/76002

Availability: http://earchive.tpu.ru/handle/11683/76002

Полиметилметакрилат в водах Вилейско-Минской водной системы

Subject Terms: органическое стекло, загрязнение рек, река Свислочь, полиметилметакрилат, Свислочь, река, полимерные микрочастицы, отбор микрочастиц

File Description: application/pdf

Access URL: https://elib.belstu.by/handle/123456789/48390

Quantitative Determination of Ivermectin in Polymer Microspheres ; Количественное определение ивермектина в составе полимерных микрочастиц

Authors: A. I. Mogaibo, A. V. Meleshko, V. V. Suslov, O. I. Rybchenko, Yu. M. Domnina, S. A. Kedik, А. И. Могайбо, А. В. Мелешко, В. В. Суслов, О. И. Рыбченко, Ю. М. Домнина, С. А. Кедик

Source: Drug development & registration; Том 11, № 1 (2022); 90-97 ; Разработка и регистрация лекарственных средств; Том 11, № 1 (2022); 90-97 ; 2658-5049 ; 2305-2066

Subject Terms: валидация, polymer microparticles, high-performance liquid chromatography, validation, полимерные микрочастицы, высокоэффективная жидкостная хроматография

File Description: application/pdf

Relation: https://www.pharmjournal.ru/jour/article/view/1166/950; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1166/1040; Meleny W. P. Abstract Paper: 61st Annual Meeting of the Conference of Research Workers in Animal Diseases. Chicago: Ill, USA; 1980.; Burg R. W., Miller B. M., Baker E. E. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrobial Agents and Chemotherapy. 1979;15(3):361–367 DOI:10.1128/aac.15.3.361.; Soll M. D., Carmichael I. H., Swan G. E., Scherer H. Control of cattle mange in southern africa using ivermectin. Tropical Animal Health and Production. 1987;19(2):93–102 DOI:10.1007/bf02297327.; Dorati R., Genta I., Colzani B., Tripodo G., Conti B. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters. Drug Development and Industrial Pharmacy. 2015;41(7):1182–1192. DOI:10.3109/03639045.2014.935395.; Lifschitz A., Virkel G., Ballent M., Sallovitz J., Imperiale F., Pis A., Lanusse C. Ivermectin (3.15%) long-acting formulations in cattle: Absorption pattern and pharmacokinetic considerations. Veterinary parasitology. 2007;147:303–310. DOI:10.1016/j.vetpar.2007.04.009.; Campbell W. C., Fisher M. H., Stapley E. O. Ivermectin: a potent new antiparasitic agent. Science. 1983;221(4613):823–828 DOI:10.1126/science.6308762.; Pulliam J. D., Seward R. L., Henry R. T., Steinberg S. A. Investigating ivermectin toxicity in collies. Veterinary Medicine. 1985;80:33–40.; Mendes A. M., Albuquerque I. S., Machado M., Pissarra J., Meireles P., Prudencio M. Inhibition of Plasmodium liver infection by ivermectin. Antimicrob Agents Chemiother. 2017;61:1–9. DOI:10.1128/AAC.02005-16.; Caly L., Druce J. D., Catton M. G., Jans D. A., Wagstaff K. M. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 2020;178:104787 DOI:10.1016/j.antiviral.2020.104787.; Arévalo A. P., Pagotto R., Pórfido J. L., Daghero H., Segovia M., Yamasaki K., Varela B., Hill M., Verdes J. M., Duhalde Vega M., Bollati-Fogolín M., Crispo M. Ivermectin reduces in vivo coronavirus infection in a mouse experimental model. Scientific Reports. 2021;11(1):7132. DOI:10.1038/s41598-021-86679-0.; Zaheer T., Pal K., Abbas R. Z., del Pilar Rodríguez Torres M. COVID-19 and ivermectin: Potential threats associated with human use. Journal of Molecular Structure. 2021;1243:130808. DOI:10.1016/j.molstruc.2021.130808.; Tavares E. J. M., De Araújo D. R., Fraceto, L. F. Ivermectin-loaded polymeric nanoparticles: Screening the effects of polymers, methods, and the usefulness of mathematical models. Journal of Nanoscience and Nanotechnology. 2017;17(6):4218–4234. DOI:10.1166/jnn.2017.13111.; Devaka N., Rao V. Chromatographic Quantification of Ivermectin and Pranziquantel in the Tablets Using Stability Indicating RP-HPLC Method. Pharmaceutical Sciences. 2019;25(3):254–261. DOI:10.15171/PS.2019.41.; Nischal K., Somshekar B., Abhilekha P. M., Sharadamma K. C., Radhakrishna P. M. A Simple RP-HPLC Method for Estimation of Triclabendazole and Ivermectin in a Pharmaceutical Suspension Dosage Form. Current Pharma Research. 2011;1(4):306–310 DOI:10.33786/JCPR.2011.V01I04.003.; Vegad K. L., Paranjape D. B., Shah D. A., Patel E. D., Patel Y. K., Patel K. R. Development and validation of RP-HPLC method for simultaneous estimation of ivermectin and clorsulon in ivercam injection. Indo American Journal of Pharmaceutical Research. 2017;7(08):523–531.; Dorati R., Genta I., Colzani B., Modena T., Bruni G., Tripodo G., Conti B. Stability Evaluation of Ivermectin-Loaded Biodegradable Microspheres. AAPS PharmSciTech. 2015;16(5):1129–1139 DOI:10.1208/s12249-015-0305-1.; Dorati R., Conti B., Colzani B., Dondi D., Lazzaroni S., Modena T., Genta I. Ivermectin controlled release implants based on poly-D,L-lactide and poly-ε-caprolactone. Journal of Drug Delivery Science and Technology. 2018;4:101–110. DOI 10.1016/j.jddst.2018.04.014.; Рыбченко О. И., Суслов В. В., Домнина Ю. М., Инкапсулирование ивермектина в микрочастицы поликапролактона. В кн.: Научные исследования молодых ученых: сборник статей XII Международной научно-практической конференции. Пенза: МЦНС «Наука и Просвещение»; 2021. С. 226–230. Доступно по: https://naukaip.ru/wp-content/uploads/2021/06/%D0%9C%D0%9A-1137.pdf. Ссылка активна на 09.08.2021.; ГФ XIV ОФС.1.1.0012.15. Валидация аналитических методик. Доступно по: https://pharmacopoeia.ru/ofs-1-1-0012-15-validatsiyaanaliticheskih-metodik/ Ссылка активна на 09.08.2021.; https://www.pharmjournal.ru/jour/article/view/1166

Availability: https://www.pharmjournal.ru/jour/article/view/1166
https://doi.org/10.33380/2305-2066-2022-11-1-90-97

DOSAGE FORMS OF NONSTEROIDAL ANTI-INFLAMMATORY PHARMACEUTICAL SUBSTANCE FOR CONTROLLED RELEASE ; ЛЕКАРСТВЕННЫЕ ФОРМЫ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ СРЕДСТВ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ

Authors: S. A. Kedik, V. V. Suslov, I. P. Sedishev, T. T. Nguen, E. A. Shnyak, С. А. Кедик, В. В. Суслов, И. П. Седишев, Т. Т. Нгуен, Е. А. Шняк

Source: Drug development & registration; № 2 (2017); 74-83 ; Разработка и регистрация лекарственных средств; № 2 (2017); 74-83 ; 2658-5049 ; 2305-2066

Subject Terms: модифицированное высвобождение, polymeric microparticles, controlled release, полимерные микрочастицы

File Description: application/pdf

Relation: https://www.pharmjournal.ru/jour/article/view/410/405; A.A. Mansour. Cox-2 specific inhibitors (COXIBS) crisis // Basrah Journal of Surgery. 2003. V.9. P. 138-143.; T. Ramasamyab, H.B. Ruttalac, S. Shanmugamd, S.K. Umadevi. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis // Drug Delivery. 2013. V. 20. P. 65-77.; C. Sostres, C.J. Gargallo, M.T. Arroyo, A. Lanas. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract // Best Practice Research Clinical Gastroenterology. 2010. V. 24. P. 121-132.; A.H.A. Hassanein, M.A.E. Abdelrahim, A.S.A. Said, R.R.S. Hussein, M. Abuseif. The incidence of upper gastrointestinal complications of non-steroidal anti-inflammatory drugs in elderly patients // Medicine Science. 2014. V. 3. P. 1032-1045.; J.F. Fries, C.A. Williams, D.A. Bloch. The relative toxicity of nonsteroidal anti-inflammatory drugs // Arthritis Rheum. 1991. V. 34. P. 1353-1357.; A.H. El-Kamel, M.S. Sokar, S.S. Al Gamal, V.F. Naggar. Preparation and evaluation of ketoprofen floating oral delivery system // Int.J.Pharm. 2001. V. 220. P. 13-21.; М.Ю. Леонова, Ю.Б. Белоусов. Лекарственные формы с модифицированным высвобождением и системы доставки лекарств. - М.: Литтерра, 2011. 655 с.; Patent US № 6217911. Sustained release non-steroidal, antiinflammatory and lidocaine PLGA microspheres / W.M. Vaughn, J.E. van Hamont, J.A. Setterstrom.; P. Del Gaudio, P. Russo, M.R. Lauro, P. Colombo, P. Rita. Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release // AAPS Pharm.Sci.Tech. 2009. V. 10. P. 1178-1185.; К.В. Алексеев, Е.В. Блынская, С.А. Кедик. Фармацевтическая нанотехнология: учебное пособие. - М.: Институт фармацевтических технологий. 2012. 542 с.; Е.С. Жаворонок, С.А. Кедик, А.В. Панов, Е.А. Петрова, В.В. Суслов. Полимерные микрочастицы для медицины и биологии: учеб. пособие. - М.: ИФТ, 2014. 480 с.; Long acting injections and implants / Ed. by C.W. Wright, D.J. Burgess. - N.Y.: Springer, 2012. 458 p.; Microincapsulation. Methods and industrial applications / Ed. by S. Benita. - N.Y.: Taylor and Francis, 2006. 756 p.; В.А. Лившиц, А.П. Бонарцев, А.Л. Иорданский, Е.А. Иванов, Т.А. Махина, В.Л. Мышкина, Г.А Бонарцева. Микросферы из поли-3-гидроксибутирата для пролонгированного высвобождения лекарственных веществ // Высокомолекулярные соединения, Сер. А. 2009. Т. 51. № 7. С. 1243-1251.; Е.А. Петрова. Разработка состава и технологии получения инъекционной лекарственной формы налтрексона с модифированным высвобождением: Дисс. канд. фарм. наук. - М. 2014. 147 с.; P. Singh , V.K. Chaudhari, P.K. Verma, A.K. Singh, V.K. Yadav. Multiunit floating drug delivery system a significant tool for the treatment of peptic ulcer disease // Int. J Pharm. Sci. Res. 2015. V. 6. P. 1351-1362.; J. Sjoegren, L.F. Prescott, W.S. Nimmoe. Rate Control in Drug Therapy - Edinburgh: Churchill Livingstone, 1985. P. 38-47.; F. Castelli, B. Conti, D.E. Maccarrone, U. Conte, G. Puglisi. Comparative study of ‘in vitro’ release of anti-inflammatory drugs from polylactide-co-glycolide microspheres // Int. J. Pharm. 1998. V. 176. P. 85-98.; К.В. Алексеев, И. А. Грицкова, С. А. Кедик. Полимеры для фармацевтической технологии: учебное пособие. - М. 2011. 511 с.; M.N. Ranjha, H. Khan, S. Naseem. Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent // J Mater Sci: Mater Med. 2010. V. 21. P. 1621-1630.; C. Sankar, B. Mishra. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration // Acta Pharm. 2003. V. 53. P. 101-110.; S.K. Noveen Kumar Reddy, V.R. Ravi Kumar, R. Revathi, V. Ganesan. Preparation and evaluation of ethyl cellulose microspheres of ibuprofen for sustained drug delivery // Int. J Pharm. Res. 2010. V. 2. Is. 8. A. 019; С.А. Кедик, Е.С. Жаворонок, И.П. Седишев, А.В. Панов, В.В. Суслов, Е.А. Петрова, М.Д. Сапельников, Д.О. Шаталов, Д.В. Ерёмин. Полимеры для систем доставки лекарственных веществ пролонгированного действия (обзор). Полимеры и сополимеры молочной и гликолевой кислот // Разработка и регистрация лекарственных средств. 2013. № 2 (3). С. 18-35.; W.B. Liechty, D.R. Kryscio, B.V. Slaughter, N.A. Peppas. Polymers for drug delivery systems // Annu. Rev. Chem. Biomol. Eng. 2010. V. 1. P. 149-173.; T. Ramasamy, S.K. Noveenkumar reddy, V.R. Ravi Kumar, R. Revathi, V. Ganesan. Eudragit-coated aceclofenac-loaded pectin microspheres in and on cell membrane molecular models // Biophysical Chem. 2010. V. 147. P. 53-58.; В.И. Севастьянов, М.П. Кирпичников. Биосовместимые материалы. - М.: Медицинское информационное агентство. 2011. 408 с.; B.K. Nanjwade, H.M. Bechra, G.K. Derkar, F.V. Manvi, V.K. Nanjwade. Dendrimers: Emerging polymers for drug-delivery systems // Eur. J Pharm. Sci. 2009. V. 38. Р. 185-196.; A.V.R. Urs, K. Kavitha, G.N. Sockan. Albumin microspheres: an unique system as drug delivery carriers for non steroidal anti-inflammatory drugs (nsaids) // Int. J Pharm. Sci. Rev. Res. 2010. V. 5. Issue 2. Р. 2799-2813.; R. Abdeen, N. Salahuddin. Modified chitosan-clay nanocomposite as a drug delivery system intercalation and in vitro release of ibuprofen // Hindawi Publishing Corporation J Chem. 2013. P. 9.; S. Abd El-Rasoul, M.M. Ahmed. Chitosan polymer as a coat of calcium alginate microcapsules loaded by non-steroidal antiinflammatory drug. // Bull. Pharm. Sci., Assiut Univ. 2010. V. 33. P. 179-186.; J. Shaji, V. Jain, S. Lodha. Chitosan: a novel pharmaceutical excipient // Int. J Pharm. Applied Sci. 2010. V. 1. P. 50-53.; J.H. Hamman. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. // Mar. Drugs. 2010. V. 8. P. 1305-1322.; Е.А. Петрова, С.А. Кедик, К.В. Алексеев, Е.В. Блынская, А.В. Панов, В.В. Суслов, Н.В.Тихонова. Оценка эффективности метода двойного эмульгирования при получении микросфер налтрексона на основе сополимера молочной и гликолевой кислот // Вестник МИТХТ. 2013. Т. 8. № 2. С. 58-63.; A. Verma, A. Tripathi, S.A. Saraf, S. Saraf. Fabrication and evaluation of sustained release microspheres of ketorolac tromethamine // Int. J Pharm. and Pharm. Sci. 2010. V. 2. Suppl. 4.; C. Nagda, N.P. Chotai, U. Patel, S. Patel, T. Soni, P. Patel, L. Hingorani. Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac // Drug Devel. Ind. Pharm. 2009. V. 35. P. 1155-1166.; P. Giunchedi, B. Conti, L. Maggi, U. Conte. Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation // J Microencapsul. 1994. V. 11. P. 381-393.; H. Ichikawa, Y. Fukumori, C.M. Adeyeye. Design of prolonged-release microcapsules containing diclofenac sodium for oral suspensions and their preparation by the Wurster process // Int. J Pharm. 1997. V. 156. P. 39-48.; Е.А. Петрова, С.А. Кедик, К.В. Алексеев, Е.В. Блынская, А.В. Панов, В.В. Суслов, Н.В. Тихонова. Изучение параметров микроинкапсулирования при получении пролонгированной формы налтрексона // Хим. фарм. ж. 2014. Т. 48. № 1. С. 50-53.; A.K. Dhamankar, J.V. Manwar, D.D. Kumbhar. The novel formulation design of O/W microemulsion of ketoprofen for improving transdermal absorption // Int. J Pharm.Tech. Res. 2009. V. 1. P. 1449-1457.; Т.Т.Т. Нгуен, С.А. Кедик, В.В. Суслов, Е.А. Шняк, Е.В. Ворфоломеева, Е.В. Никонорова. Разработка метода получения полимерных микросфер, содержащих иммобилизованный диклофенак // Тонкие хим. технологии. 2015. Т.10. № 4. С. 27-31.; R. Bodmeier, H. Chen. Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen // J Controlled Release. 1989. V. 10. P. 167-175.; M. Najmuddin, S.S. Asgar ali, V. Patel, T. Khan. Formulation and in vitro evaluation of floating microspheres of ketoprofen prepared by emulsion solvent diffusion method // Int. J Appl. Pharm. 2010. V. 2. P. 1-15.; A.K. Saha, S.D. Ray. Effect of cross-linked biodegradable polymers on sustained release of sodium diclofenac-loaded microspheres // Brazilian J Pharm. Sci. 2013. V. 49. P. 873-888.; N.G. Raghavendra Rao, U. Kulkarni, A. Deshmukh, D.K. Suresh. Preparation and characterization of ionotropic cross-linked chitosan microparticles for controlled release of aceclofenac // Int. J Pharm. Sci. Drug Res. 2010. V. 2. P. 107-111.; S.G. Kumbar, A.R. Kulkarni, M. Aminabhavi. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent // J Microencapsul. 2002. V. 19. P. 173-180.; S.T. Mathew, S.G. Devi, K.V Sandhya. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration // AAPS Pharm.Sci.Tech. 2007. V. 8. P. 100-108.; A. Aggarwal, S. Kaur, F.K. Tiwary, S. Gupta. Chitosan microspheres prepared by an aqueous process: release of indomethacin // J Microencapsul. 2001. V. 18. P. 819-823.; F. Pavanetto, P. Perugini, B. Conti, T. Modena, I. Genta. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method // J Microencapsul. 1996. V. 130. P. 679-880.; M.S. Roy, B.K. Gupta. Indomethacinloaded microspheres: design and preparation by a multiple-emulsification technique and their in vitro evaluation // Pharm. Res. 1992. V. 9. P. 1132-1136.; M.L. Gonzalez-Rodriguez, M.A. Holgado, C. Sanchez-Lafuente, A.M. Rabasco, A. Fini. Alginate/chitosan particulate systems for sodium diclofenac release // Int. J Pharm. 2002. V. 232. P. 225-234.; M.A. Bayomi. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin // Drug Dev. Ind. Pharm. 2004. V. 30. P. 329-339.; W.J. Lin, W.W. Kang. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method. // J Microencapsul. 2003. V. 20. P. 169-177.; B. Devrim, A. Bozkir, K. Canefe. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres //.Acta Pol. Pharm. 2011. V. 68. P. 593-599.; C.Y. Yang, S.Y. Tsay, R.C.C. Tsiang. An enhanced process for ethyl cellulose microcapsules by solvent evaporation in an O/W emulsion // J Microencapsul. 2000. V. 17. P. 269-277.; C.Y. Yang, S.Y. Tsay, R.C.C. Tsiang. Encapsulating aspirin into a surfactantfree ethyl cellulose microsphere using non-toxic solvents by emulsion solvent evaporation technique // J Microencapsul. 2001. V. 18. P. 223-236.; Q.Y. Guo, L.W. Chan, P.W.S. Heng. Investigation of the release of aspirin from spray-congealed micro-pellets // J Microencapsul. 2005. V. 22. P. 245-251.; V.D. Vilivalam, C.M. Adeyeye. Development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres // J Microencapsul. 1994. V. 11. P. 455-470.; S.Y. Lin, K.S. Chen, H.H. Teng, M.J. Li. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters // J Microencapsul. 2000. V. 17. P. 577-586.; Т.Т. Нгуен Тхи, С.А. Кедик, В.В. Суслов, Е.А. Шняк, Е.В. Ворфоломеева, Е.В. Никонорова. Разработка метода получения полимерных микросфер, содержащих иммобилизованный диклофенак // Тонкие химические технологии. 2015. Т. 10. № 1. С. 56-59.; K.M. Manjanna, B. Shivakumar, T.M. Pramod Kumar. Microencapsulation: an acclaimed novel drug-delivery system for nsaids in arthritis // J Digital Library. 2010. V. 27. P. 509-545.; M. Tuncay, S. Calis, H.S. Kas, M.T. Ercan, I. Peksoy, A.A. Hincal. In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres // J Microencapsul. 2000. V. 17. P. 145-155.; C. Sajeev, G. Vinay, R. Archna, R.N. Saha. Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose // J Microencapsul. 2002. V. 19. P. 753-760.; M. Eltayeb, E. Stride, M. Edirisinghe. Preparation, characterization and release kinetics of ethylcellulose nanoparticles encapsulating ethylvanillin as a model functional component // J Func. Foods. 2015. V. 14. P. 726-735.; P. Sipos, I. Csóka, S. Srčič, K.a PintyeHódi, I. Erős. Influence of preparation conditions on the properties of Eudragit microspheres produced by a double emulsion method // J Drug Devel. Res. 2005. V. 64. P. 41-54.; A.G.E. Rsoy, S.C. EvIk. Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium // J Microencapsul. 2000. V. 17. P. 565-575.; P.M. Satturwar, P.M. Mandaogade, A.K. Dorle. A novel method for preparation of Eudragit RL microcapsules // J Microencapsul. 2002. V. 19. P. 407-413.; M.C. Adeyeye, E. Mwangi, B. Katondo, A. Jain, H. Ichikawa, Y. Fukumori. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragitbased formulation and possible drugexcipient interaction // J Microencapsul. 2005. V. 22. P. 333-342.; M.E. Palomo, M.P. Ballesteros, P. Frutos. Solvent and plasticizer influences on ethylcellulose-microcapsules // J Microencapsul. 1996. V. 13. P. 307-318.; S.S. Biju, S. Saisivam, N.S.M.G. Rajan, P.R. Mishra. Dual coated erodible microcapsules for modified release of diclofenac sodium // Eur. J Pharm. Biopharm. 2004. V. 58. P. 61-67.; R. Pignatello, D. Amico, S. Chiechio, C. Spadaro, G. Puglisi, P. Giunchedi. Preparation and analgesic activity of Eudragit RS100® microparticles containing diflunisal // Drug Delivery. 2001. V. 8. P. 35-45.; D. Perumal. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique // Int. J Pharm. 2001. V. 218. P. 1-11.; S. Tamilvanan, B. Sa. Effect of production variables on the physical characteristics of ibuprofen-loaded polystyrene microparticles // J Microencapsul. 1999. V. 16. P. 411-418.; G. Weiβ, A. Knoch, A. Laicher, F. Stanislaus, R. Daniels. Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP) II. Microencapsulation of ibuprofen // Int. J Pharm. 1995. V. 124. P. 97-105.; R. Pignatello, C. Bucolo, P. Ferrara, A. Maltese, A. Puleo, G. Puglisi. Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen // Eur. J Pharm. Sci. 2002. V. 16. P. 53-61.; E.S. Ghaly, S. Sepulveda. In vitro evaluation of sustained release ibuprofen microspheres // P R Health Sci. J. 1996. V. 15. P. 97-100.; M. Saravanan, K. Bhaskar, G. Srinivasa Rao, M.D. Dhanaraju. Ibuprofenloaded ethylcellulose/polystyrene microspheres: an approach to get prolonged drug release with reduced burst effect and low ethylcellulose content // J Microencapsul. 2003. V. 20. P. 289-302.; S. Tirkkonen, L. Turakka, P. Paronen. Microencapsulation of indomethacin by gelatin-acacia complex coacervation in the presence of surfactants // J Microencapsul. 1994. V. 11. P. 615-626.; S. Tirkkonen, P. Paronen. Release of indomethacin from tabletted ethylcellulose microcapsules // Int. J Pharm. 1993. - V. 92. P. 55-62.; D. Ermis, A. Yuksel. Preparation of spraydried microspheres of indomethacin and examination of the effects of coating on dissolution rates // J Microencapsul. 1999. V. 16. P. 315-324.; I.L. Gyun Shin, S.Y. Kim, Y.M. Lee, C.S. Cho, Y.K. Sung. Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization // J Contr. Release. 1998. V. 51. P. 1-11.; W. Tiyaboonchai1, G.C. Ritthidej. Development of indomethacin sustained release microcapsules using chitosancarboxymethylcellulose complex coacervation // J Sci. Technol. 2003. V. 25. P. 245-254.; T. A. Ahmed, B. M. Aljaeid. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery // Drug Design Develop. Therapy. 2016. V. 10. P. 483-494.; El-Gibaly, S.M. Safwat, M.O. Ahmed. Microencapsulation of ketoprofen using w/o/w complex emulsion technique // J Microencapsul. 1996. V. 13. P. 67-87.; G.F. Palmieri, G. Bonacucina, P.D. Martino, S. Martelli. Gastro-resistant microspheres containing ketoprofen. // J Microencapsul. - 2002. V. 19. P. 111-119.; P. Giunchedi, M.L. Torre, L. Maggi, B. Conti, U. Conte. Cellulose acetate trimellitate ethylcellulose blends for non-steroidal anti-inflammatory drug (NSAID) microspheres // J Microencapsul. 1996. V. 13. P. 89-98.; T. Mateović-Rojnik, R. Frlan, M. Bogataj, P. Bukovec, A. Mrhar. Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties // Chem. Pharm. Bull. 2005. V. 53. P. 143-146.; S. Goto, M. Kawata, M. Nakamura, K. Maekawa, T. Aoyama. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen // J Microencapsul. 1986. V. 3. P. 293-304.; T. Yamada, H. Onishi, Y. Machida. In vitro and in vivo evaluation of sustained release chitosan-coated ketoprofen microparticles // Yakugaku Zasshi. 2001. V. 121. P. 239-245.; V.R. Sinha, R.V. Kumar, G. Singh. Ketorolac tromethamine formulations: an overview // Expert Opinion Drug Delivery. 2009. V. 6. P. 961-975.; T.M. Sam, D.S. Gayathri, V.V. Prasanth, B. Vinod. Characterization and pharmacokinetic evaluation of gamma sterilized ketorolac tromethamine loaded albumin microspheres for intramuscular administration // Current Drug Delivery. 2013. V. 10. P. 158-166.; S. Bhaskaran, M. Sanmathi. Poly(lactic acid) microspheres of ketorolac tromethamine for parenteral controlled drug delivery system // Indian J Pharm. Sci. 2001. V. 40. P. 538-545.; H. Wu, M.A. Khan. Quality-by-design: аn integrated process analytical technology approach to determine the nucleation and growth mechanisms during a dynamic pharmaceutical coprecipitation process // J Pharm. Sci. 2011. V. 100. P. 1969-1986.; Y. Javadzadeh, F. Ahadi, S. Davaran, G. Mohammadi, A. Sabzevari, K. Adibkia. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles // Coll. Surfaces B: Biointerfaces. 2010. V. 81. - P. 498-502.; https://www.pharmjournal.ru/jour/article/view/410

Availability: https://www.pharmjournal.ru/jour/article/view/410

Полиметилметакрилат в водах Вилейско-Минской водной системы

Authors: Волобуев, Влас Сергеевич, Эминов, Э. М.

Subject Terms: полиметилметакрилат, отбор микрочастиц, Свислочь, река, река Свислочь, загрязнение рек, органическое стекло, полимерные микрочастицы

File Description: application/pdf

Relation: https://elib.belstu.by/handle/123456789/48390; 502.51:504.5

Availability: https://elib.belstu.by/handle/123456789/48390